UCSF
Doctors will be able to test patients for 17 genes known to influence response to 62 drugs and receive guidance from EHR-embedded pre- and post-test alerts.
Personalis, UCSF to Study ctDNA Utility in Colorectal Cancer Treatment Response Monitoring
Researchers will employ the company's tumor-informed, personalized assays to analyze ctDNA patterns linked to immunotherapy drug response.
Five research groups participating in the NHGRI-funded Molecular Phenotypes of Null Alleles in Cells initiative aim to characterize 1,000 null alleles in a pilot phase.
NIH Launches $500M Effort to Map Cells of the Human Brain
The BRAIN Initiative Cell Atlas Network (BICAN) will rely heavily on single-cell sequencing and bioinformatics to create brain cell atlases and maps of cell interactions.
Gut Microbiome in Multiple Sclerosis Varies by Disease Course, Treatment Approach
Researchers from the International Multiple Sclerosis Microbiome Study compared the gut microbiomes of MS patients and healthy household controls.